You are here

The Hep C Review No.24

Publication type: 
Newsletter
AttachmentSize
PDF icon chodarr1209.pdf1.87 MB
Agency: 
Hepatitis C Council of NSW
Sponsor: 
NSW Health
Series: 
24 of 30
Date: 
1999-03
Pages: 
44
Summary: 
Issue # 24 of the Hep C Review contains articles for members of the Hep C Council of NSW on the newly approved US FDA combination therapy of interferon/ribavirin for the treatment of HCV. Side effects of medical and herbal treatments as well as the regular feature columns on prevention, interferon, complementary therapies, support services and HCV information in Australia.
Keywords: 
Hepatitis Council of NSW; hepatitis c; hepatitis c virus infection; alternative therapies; treatment; vaccine; interferon; ribavirin; research; social support; nutrition; exercise; cirrhosis; liver function tests; neutriceuticals; research; disability; advocacy; social security; drug use; harm reduction; alcohol use; liver function tests; legal issues; discrimination; prevention; chronic illness; epidemic; genotype; needle exchange; prison; prisoner; naturopathy; homeopathy;